Format

Send to

Choose Destination
See comment in PubMed Commons below
Arch Intern Med. 2004 Feb 9;164(3):317-9.

A population-based study of the incidence, cause, and severity of anaphylaxis in the United Kingdom.

Author information

  • 1Boston Collaborative Drug Surveillance Program, Boston University School of Medicine, Lexington, MA 02421, USA.

Abstract

BACKGROUND:

Anaphylaxis is an acute and potentially fatal systemic reaction usually caused by mast cell-mediated release of histamine. Symptoms can vary in onset, appearance, and severity. Some common symptoms include weakness, dizziness, flushing, angioedema, urticaria, nasal congestion, and sneezing. Severe symptoms include upper respiratory tract obstruction, hypotension, vascular collapse associated with angioedema and urticaria, gastrointestinal distress, cardiovascular arrhythmias, and/or arrest.

METHODS:

We conducted an observational follow-up study encompassing approximately 8 million person-years based on the UK General Practice Research Database for the period January 1, 1994, to December 31, 1999, which quantified the frequency, type, and severity of a clinical diagnosis of anaphylaxis.

RESULTS:

Based on 675 cases of anaphylaxis, we estimate the incidence to be 8.4 per 100 000 person-years. Approximately 10% of cases had hypotension and shock that required urgent treatment. The most common causes were insect stings and oral medicines.

CONCLUSION:

Anaphylaxis is an uncommon illness that has multiple causes and can be life-threatening.

PMID:
14769628
DOI:
10.1001/archinte.164.3.317
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Silverchair Information Systems
    Loading ...
    Support Center